Prescribing Trends and Comparative Risk of Type 2 Diabetes Progression in Prediabetes by Antihyperglycemic Drug Class
by Prateek Chopra | June 24, 2026 | Diabetes Conferences | ADA 2026 Need for Diabetes Prevention Methods Primary Outcome Risk of Progression to Type 2 Diabetes Clinical Implications In this large real-world analysis, GLP-1RAs, GIP/GLP-1RAs, and SGLT2 inhibitors were associated with significantly lower rates of incident T2D compared with metformin. Among these therapies, GIP/GLP-1RAs provided the greatest protection against […]